|
May explain what the problem behind the holdup is.
|
2
|
Resverlogix Corp.
|
Jul 17, 2021 08:53AM
|
|
May get more patients from BA2 for our trial.
|
5
|
Resverlogix Corp.
|
Jan 14, 2022 12:04AM
|
|
May speed things up a bit, as the ACE2 target that RVX is looking at seems to be getting more attention.
|
4
|
Resverlogix Corp.
|
Jun 15, 2020 11:43AM
|
|
Merck's profit on Molnupiravir.
|
1
|
Resverlogix Corp.
|
Oct 08, 2021 01:53AM
|
|
Molnupiravir.
|
1
|
Resverlogix Corp.
|
Sep 27, 2021 08:16PM
|
|
Morocco?
|
2
|
Resverlogix Corp.
|
Nov 03, 2021 01:14AM
|
|
Mutations could render current Covid vaccines ineffective in a year or less, epidemiologists warn.
|
5
|
Resverlogix Corp.
|
Apr 01, 2021 02:13AM
|
|
My take on these classics by our Hub Leader!
|
7
|
Resverlogix Corp.
|
Jun 15, 2020 05:41PM
|
|
Neuropilin-1 is a host factor for SARS-CoV-2 infection.
|
3
|
Resverlogix Corp.
|
Oct 21, 2020 12:06PM
|
|
New name.
|
3
|
Resverlogix Corp.
|
May 10, 2022 07:11PM
|
|
New strategy for fighting brain cancer.
|
5
|
Resverlogix Corp.
|
Apr 19, 2021 02:01PM
|
|
New treatment for COVID-19 discovered in human skin cells.
|
3
|
Resverlogix Corp.
|
Mar 11, 2022 02:11AM
|
|
Nice to read one employee's assessment about EVERSANA.
|
7
|
Resverlogix Corp.
|
Jul 14, 2021 12:22PM
|
|
No change in Ottawa.
|
2
|
Resverlogix Corp.
|
Sep 21, 2021 12:41AM
|
|
Not adding up!
|
2
|
Zenith Epigenetics
|
Nov 15, 2021 10:37AM
|
|
Notice the attention this is getting in the media?
|
7
|
Resverlogix Corp.
|
Apr 29, 2021 12:46AM
|
|
October 1.
|
3
|
Resverlogix Corp.
|
Oct 01, 2021 02:30PM
|
|
One more horse in this race.
|
5
|
Zenith Epigenetics
|
Jun 29, 2020 02:14PM
|
|
One week later....
|
6
|
Resverlogix Corp.
|
May 19, 2021 12:22PM
|
|
Ontario becomes the first province to list fluvoxamine as a COVID-19 treatment to consider.
|
3
|
Resverlogix Corp.
|
Dec 22, 2021 11:45PM
|
